Virginia Retirement Systems’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Sell |
19,669
-300
| -2% | -$10.9K | ﹤0.01% | 672 |
|
|
2025
Q1 | $723K | Buy |
+19,969
| New | +$723K | 0.01% | 651 |
|
|
2023
Q3 | $510K | Buy |
14,300
+3,500
| +32% | +$125K | 0.01% | 691 |
|
|
2023
Q2 | $498K | Buy |
10,800
+900
| +9% | +$41.5K | ﹤0.01% | 719 |
|
|
2023
Q1 | $397K | Buy |
9,900
+4,300
| +77% | +$172K | ﹤0.01% | 807 |
|
|
2022
Q4 | $259K | Sell |
5,600
-500
| -8% | -$23.2K | ﹤0.01% | 1007 |
|
|
2022
Q3 | $253K | Buy |
+6,100
| New | +$253K | ﹤0.01% | 991 |
|
|
2022
Q1 | $763K | Sell |
10,500
-3,400
| -24% | -$247K | 0.01% | 731 |
|
|
2021
Q4 | $1.17K | Buy |
13,900
+1,600
| +13% | +$135 | 0.01% | 617 |
|
|
2021
Q3 | $1.11M | Buy |
12,300
+2,100
| +21% | +$189K | 0.01% | 580 |
|
|
2021
Q2 | $973K | Sell |
10,200
-200
| -2% | -$19.1K | 0.01% | 659 |
|
|
2021
Q1 | $1.18M | Buy |
10,400
+1,800
| +21% | +$205K | 0.01% | 597 |
|
|
2020
Q4 | $1.19M | Buy |
8,600
+4,800
| +126% | +$664K | 0.01% | 553 |
|
|
2020
Q3 | $312K | Buy |
3,800
+1,000
| +36% | +$82.1K | ﹤0.01% | 918 |
|
|
2020
Q2 | $219K | Buy |
+2,800
| New | +$219K | ﹤0.01% | 1015 |
|